Abstract
A 68-year-old man who was a former cigarette smoker was found to have atypical/suspicious cells on urinary cytology obtained during a work up for microscopic hematuria. Imaging (presumably a CT urogram) and cystoscopy did not identify an obvious tumor. He has three risk factors for urothelial cancer (UC): male, smoking history, and hematuria. The absence of a cytology that indicates “positive for cancer cells” is most important. Close follow-up by repeat cytology and possibly cystoscopy is reasonable but we would not proceed with bladder or prostatic urethra biopsies, upper tract cytology, ureteroscopy, or submitting the urine for the FISH analysis unless cells consistent with cancer are identified by an experienced cytopathologist. Such investigative procedures for an atypical report would, in our view, subject the patient to potential morbidity with a low likelihood of identifying a UC.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Britton JP. Effectiveness of haematuria clinics. Br J Urol. 1993;71(3):247–52.
Benbassat J, Gergawi M, Offringa M, Drukker A. Symptomless microhaematuria in schoolchildren: causes for variable management strategies. QJM. 1996;89:845–54.
Loo RK, Lieberman SF, Slezak JM, et al. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc. 2013;88:129–38.
Parkin DM. The global burden of urinary bladder cancer. Scand J Urol Nephrol. 2008;42:12–20.
Nieder AM, John S, Messina CR, et al. Are patients aware of the association between smoking and bladder cancer? J Urol. 2006;176:2405–8.
Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA Guideline. 2012.
Takahashi N, Glockner JF, Hartman RP, et al. Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. J Urol. 2010;183:1330–6.
Datta SN, Allen GM, Evans R, et al. Urinary tract ultrasonography in the evaluation of hematuria-areort of over 1000 cases. Ann R Coll Surg Engl. 2002;84:203–5.
Edwards TJ, Dickinson AJ, Natale S, et al. A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU. 2006;97:301–5.
Chlapoutakis K, Theocharopoulos N, Yarmentitis S, et al. Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis. Eur J Radiol. 2010;73:334–8.
Papanicolaou GN. Cytology of the urine sediment in neoplasms of the urinary tract. J Urol. 1947;57: 375–9.
Owens CL, Vandenbussche CJ, Burroughs FH, Rosenthal DL. A review of reporting systems and terminology for urine cytology. Cancer Cytopathol. 2013;121:9–14.
Muus Ubago J, Mehta V, Wojcik EM, Barkan GA. Evaluation of atypical urine cytology progression to malignancy. Cancer Cytopathol. 2013;121:387–91.
Renshaw AA. Subclassifying atypical urinary cytology specimens. Cancer. 2000;90:222–9.
Brimo F, Vollmer RT, Case B, Aprikian A, Kassouf W, Auger M. Accuracy of urine cytology and the significance of an atypical category. Am J Clin Pathol. 2009;132:785–93.
Layfield LJ, Elsheikh TM, Fili A, Nayar R, Shidham V. Papanicolaou Society of Cytopathology. Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting : the Papanicolaou Society of Cytopathology Practice Guidelines Task Force. Diagn Cytopathol. 2004;30:24–30.
Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer. 1984;53:1555–65.
Kapur U, Venkataraman G, Wojcik EM. Diagnostic significance of “atypia” in instrumented versus voided urine specimens. Cancer. 2008;114:270–4.
Nabi G, Greene D, Donnel MO. Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up? J Clin Pathol. 2004;57:365–8.
Stenberg I, Rona R, Olsfanger S, Lew S, Leibovitch I. The clinical significance of class III (suspicious) urine cytology. Cytopathol Off J Br Soc Clin Cytol. 2011;329–33.
Lokeshwar VB, Habuchi T, Grossman HB, et al. Bladder tumor markers beyond cytology: International consensus panel on bladder tumor markers. Urology. 2005;66:35–63.
Planz B, Jochims E, Deix T, et al. The role of urinary cytology for detection of bladder cancer. EJSO. 2005;31:304–8.
Raab SS, Grzybicki DM, Brbin CM, et al. Urine cytology discrepancies—frequency, causes and outcomes. Am J Clin Pathol. 2007;127:946–53.
Piaton E, Advenier AS, Benaïm G, et al. A typical urothelial cells (AUC): a Bethesda-derived wording applicable to urinary cytopathology. Ann Pathol. 2011;31(1):11–7.
Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, et al. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol. 2006;176:44–7.
Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol. 2000;164:1768–75.
Nieder AM, Soloway MS, Herr HW. Should we abandon the FISH test? Eur Urol. 2007;51:1469–71.
Tomasini JM, Konety BR. Urinary markers/cytology: what and when should a urologist use. Urol Clin North Am. 2013;40:165–73.
Tapia C, Glatz K, Obermann EC, Grilli B, Barascud A, Herzog M, et al. Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology. Cancer Cytopathol. 2011;119:404–10.
Dimashkieh H, Wolff DJ, Smith TM, Houser PM, Nietert PJ, Yang J. Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation. Cancer Cytopathol. 2013;121:591–7.
Sadek S, Soloway MS, Hook S, Civantos F. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer. J Urol. 1999;161:77–9. discussion 79–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gomez, C.S., Soloway, M.S., Caso, J.R., Rojas, C.P., Jorda, M. (2015). Clinical Scenario: Microscopic Hematuria and Atypical Cytology. In: Konety, B., Chang, S. (eds) Management of Bladder Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1881-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1881-2_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1880-5
Online ISBN: 978-1-4939-1881-2
eBook Packages: MedicineMedicine (R0)